Growth Hormone Deficiency

• FDA approval · 2016-03-17
  FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)

  The FDA approved a supplemental application for Nutropin AQ Nuspin 10 (somatropin) by Genentech, Inc.

• FDA approval · 2016-02-26
  FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for Nutropin AQ Nuspin 10 (somatropin) from Genentech, Inc., updating/expanding the product’s approv…

• FDA approval · 2015-08-06
  FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)

  The FDA approved a supplemental application for ZOMACTON (somatropin) filed by Ferring Pharmaceuticals Inc., authorizing changes to its appr…

• FDA approval · 2015-06-12
  FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)

  FDA approved a supplemental application for ZOMACTON (somatropin) from Ferring Pharmaceuticals, likely to update labeling or expand indicati…

• FDA approval · 2015-05-26
  FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for Nutropin AQ Nuspin 10 (somatropin) from Genentech, adding/confirming a formulation strength unde…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2015-01-23
  FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)

  FDA approved a supplemental application for Norditropin (somatropin) from Novo Nordisk, resulting in an approved supplemental indication/lab…

• FDA approval · 2014-07-30
  FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)

  The FDA approved a supplemental application for Humatrope (somatropin) from Eli Lilly and Company.

• FDA approval · 2013-04-19
  FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

  FDA supplemental approval for Genotropin (somatropin) from Pfizer, authorizing an approved supplemental application to modify or expand its …

• FDA approval · 2013-04-04
  FDA Approved: OMNITROPE — Supplemental Application (Sandoz Inc)

  The FDA approved a supplemental application for Omnitrope (somatropin) from Sandoz Inc, potentially expanding or updating the product’s labe…

• FDA approval · 2010-07-28
  FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)

  FDA approved a supplemental application for HUMATROPE (somatropin) submitted by Eli Lilly and Company, authorizing changes to the existing p…

• FDA approval · 2010-04-12
  FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)

  FDA approved a supplemental application for ZOMACTON (somatropin) from Ferring Pharmaceuticals Inc. The action represents an additional regu…

• FDA approval · 2010-02-02
  FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

  FDA approved a supplemental application for Genotropin (somatropin) from Pfizer Laboratories Div Pfizer Inc.

• FDA approval · 2008-01-03
  FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)

  The FDA approved a supplemental application for NUTROPIN AQ NUSPIN 10 (somatropin) by Genentech, updating/expanding its approved labeling.

• FDA approval · 2007-09-20
  FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)

  FDA approved a supplemental application for Norditropin (somatropin) from Novo Nordisk, indicating an approved update to the existing BLA.

• FDA approval · 2006-11-01
  FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)

  The FDA approved a supplemental application for HUMATROPE (somatropin) submitted by Eli Lilly and Company.

• FDA approval · 2006-10-26
  FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)

  The FDA approved a supplemental application for HUMATROPE (somatropin) submitted by Eli Lilly and Company.

• FDA approval · 2006-05-30
  FDA Approved: OMNITROPE — Original Application (Sandoz Inc)

  FDA approval notice for the original application of Omnitrope (somatropin) by Sandoz Inc, a human growth hormone product.